Glenmark Life Sciences Q2 Results: Net profit falls 20%, revenue drops 15%

Shares of Glenmark Life Sciences fell 3.9% to ₹1,034.35 on Thursday.

Leave a Reply

Your email address will not be published. Required fields are marked *